Literature DB >> 32856201

The clinical characteristics of low C4 alone in patients with systemic lupus erythematosus.

Weiji Xie1, Zeen Xiao1, Jing Xu1, Guitian Hong1, Xiaochang Xu2, Yimin Zhang2, Xialan Zhang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32856201     DOI： 10.1007/s10067-020-05367-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  7 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Serum C4 levels in patients with systemic lupus erythematosus in remission.

Authors:  M Yasuda; Y Suenaga; H Nishimukai; M Nobunaga
Journal:  Mod Rheumatol       Date:  2002-09       Impact factor: 3.023

3.  Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.

Authors:  Hejun Li; Shunping Lin; Shangchih Yang; Ling Chen; Xiangxiong Zheng
Journal:  Clin Rheumatol       Date:  2015-01-20       Impact factor: 2.980

4.  The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Authors:  D J Birmingham; F Irshaid; H N Nagaraja; X Zou; B P Tsao; H Wu; C Y Yu; L A Hebert; B H Rovin
Journal:  Lupus       Date:  2010-07-06       Impact factor: 2.911

5.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

6.  Relationship of complement activation route with clinical manifestations in Japanese patients with systemic lupus erythematosus: a retrospective observational study.

Authors:  Hiroshi Watanabe; Mitsuru Sugimoto; Tomoyuki Asano; Shuzo Sato; Eiji Suzuki; Atsushi Takahashi; Kyoko Katakura; Hiroko Kobayashi; Hiromasa Ohira
Journal:  Mod Rheumatol       Date:  2014-07-18       Impact factor: 3.023

7.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).

Authors:  W Lloyd; P H Schur
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.